Research & Discoveries

Popular Weight-Loss Drugs Not Linked to Higher Risks of Suicidality, but Small Caveat: Study

A new study in older patients suggests glucagon-like peptide-1 receptor agonists are not linked to higher suicidality risk.
Popular Weight-Loss Drugs Not Linked to Higher Risks of Suicidality, but Small Caveat: Study
fcm82/Shutterstock
Marina Zhang
|Updated:
0:00

A study published Monday in Annals of Internal Medicine found that glucagon-like peptide-1 receptor agonists (GLP-1RAs), a class of popular weight-loss and Type 2 diabetes drugs, are not linked to higher risks of suicidal ideation and behaviors.

The study involved older patients taking the drug for diabetes.

Marina Zhang
Marina Zhang
Author
Marina Zhang is a health reporter for The Epoch Times. She covers both health news and in-depth features on emerging health issues. Marina holds a bachelor's degree in biomedicine from the University of Melbourne. Contact her at [email protected].